| Literature DB >> 33372776 |
Zhuan Zhang, Yui Tamura1, Mancheng Tang, Tianzhang Qiao, Michio Sato1, Yoshihiro Otsu2, Satoshi Sasamura2, Masatoshi Taniguchi2, Kenji Watanabe1, Yi Tang.
Abstract
We report characterization of the biosynthetic pathway of the potent immunosuppressant (-)-FR901483 (1) through heterologous expression and enzymatic assays. The biosynthetic logic to form the azatricyclic alkaloid is consistent with those proposed in biomimetic syntheses and involves aza-spiro annulation of dityrosyl-piperazine to form a ketoaldehyde intermediate, followed by regioselective aldol condensation, stereoselective ketoreduction, and phosphorylation. A possible target of 1 is proposed based on the biosynthetic studies.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33372776 PMCID: PMC8094545 DOI: 10.1021/jacs.0c12352
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419